MCL Clinical Trials
1230 trials from ClinicalTrials.gov. Recruiting trials shown first.
Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver Dysfunction
COMPLETEDNCT00499811·PHASE1·National Cancer Institute (NCI)·15 enrolled
vorinostatpharmacological study
Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic Diseases
TERMINATEDNCT00376519·PHASE1·Masonic Cancer Center, University of Minnesota·3 enrolled
cyclophosphamidecyclosporinefludarabine phosphatemycophenolate mofetilTreg cell infusion+2 more
Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic Astrocytoma
COMPLETEDNCT00458731·PHASE1·National Cancer Institute (NCI)·57 enrolled
bevacizumabcediranib maleate
Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant
COMPLETEDNCT00569283·PHASE1·Asan Medical Center·18 enrolled
therapeutic allogeneic lymphocytes
MP470 in Treating Patients With Unresectable or Metastatic Solid Tumor or Lymphoma
TERMINATEDNCT00504205·NA·Astex Pharmaceuticals, Inc.·30 enrolled
multitargeted receptor tyrosine kinase inhibitor MP470laboratory biomarker analysispharmacological studypositron emission tomography
Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy
COMPLETEDNCT00416624·PHASE2·Mayo Clinic·239 enrolled
darbepoetin alfaepoetin alfafatigue assessment and managementquality-of-life assessment
An Investigational Study Drug, Palbociclib (PD-0332991), Is Being Studied In Patients With Mantle Cell Lymphoma. Patients Must Have Received Prior Treatment(s) For Mantle Cell Lymphoma.
COMPLETEDNCT00420056·PHASE1·Pfizer·17 enrolled
PD-0332991
Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer
COMPLETEDNCT00589563·PHASE2·City of Hope Medical Center·32 enrolled
anti-thymocyte globulincyclophosphamideetoposidefludarabine phosphatemelphalan+8 more
Combination Chemotherapy and Rituximab in Treating Patients With Untreated Mantle Cell Lymphoma
COMPLETEDNCT00433537·PHASE2·National Cancer Institute (NCI)·77 enrolled
bortezomibrituximabcyclophosphamidedoxorubicin hydrochloridevincristine+4 more
Clofarabine and Non-Myeloablative Allogeneic Hematopoietic Transplantation
TERMINATEDNCT00626626·PHASE1 / PHASE2·Milton S. Hershey Medical Center·8 enrolled
Clofar, Cyclophos, AlemtuzumabClofar, Cyclophos,Alemtuzumab(Ph II)
Bortezomib, Rituximab and Combination Chemotherapy in Treating Participants With Mantle Cell Lymphoma
COMPLETEDNCT00477412·PHASE1 / PHASE2·M.D. Anderson Cancer Center·107 enrolled
BortezomibCyclophosphamideCytarabineDexamethasoneDoxorubicin+3 more
Efficacy and Safety Study of Fostamatinib Tablets to Treat B-cell Lymphoma
COMPLETEDNCT00446095·PHASE1 / PHASE2·Rigel Pharmaceuticals·81 enrolled
fostamatinib
Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer
COMPLETEDNCT00787761·PHASE2·Northside Hospital, Inc.·24 enrolled
anti-thymocyte globulinbusulfancyclophosphamidefludarabine phosphatemethotrexate+2 more
Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
COMPLETEDNCT00489203·PHASE2·Fred Hutchinson Cancer Center·140 enrolled
beclomethasone dipropionateplacebotacrolimusmethotrexateallogeneic hematopoietic stem cell transplantation
Fludarabine, Busulfan, and Antilymphocyte Globulin Followed by Donor Stem Cell Transplant in Treating Older Patients With Hematological Cancer
COMPLETEDNCT00806767·PHASE2·Institut Paoli-Calmettes·82 enrolled
therapeutic immune globulinbusulfanfludarabine phosphateallogeneic hematopoietic stem cell transplantation
Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases
COMPLETEDNCT00438958·PHASE3·The Canadian Blood and Marrow Transplant Group·230 enrolled
filgrastimallogeneic bone marrow transplantationperipheral blood stem cell transplantation
Study of Intravenously Administered SNS-032 in Patients With Advanced B-lymphoid Malignancies
COMPLETEDNCT00446342·PHASE1·Sunesis Pharmaceuticals·21 enrolled
SNS-032 Injection
Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases
COMPLETEDNCT00453206·NA·Wake Forest University Health Sciences·66 enrolled
allogeneic bone marrow transplantationallogeneic hematopoietic stem cell transplantationnonmyeloablative allogeneic hematopoietic stem cell transplantationperipheral blood stem cell transplantation
Aurora Kinase Inhibitor AT9283 in Treating Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin's Lymphoma
COMPLETEDNCT00443976·PHASE1·NCIC Clinical Trials Group·35 enrolled
Aurora kinase inhibitor AT9283
Bortezomib and Gemcitabine in Treating Patients With Relapsed Mantle Cell Lymphoma
COMPLETEDNCT00377052·PHASE2·NCIC Clinical Trials Group·29 enrolled
bortezomibgemcitabine hydrochloride
AT7519M in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory Non-Hodgkin's Lymphoma
COMPLETEDNCT00390117·PHASE1·NCIC Clinical Trials Group·34 enrolled
CDKI AT7519laboratory biomarker analysis
Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
NO LONGER AVAILABLENCT00423826·Barbara Ann Karmanos Cancer Institute
BusulfanCytarabineFludarabine phosphatemycophenolate mofetiltacrolimus+3 more
Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases
COMPLETEDNCT00424242·EARLY_PHASE1·Northwestern University·15 enrolled
Pemetrexed
Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant
COMPLETEDNCT00964821·City of Hope Medical Center·459 enrolled
trivalent influenza vaccineImmunoenzyme techniqueLaboratory biomarker analysis
Phase III, Multicentre, Randomised Study of Fludarabine/Cyclophosphamide Combination With or Without Rituximab in Patients With Untreated Mantle Cell Lymphoma
COMPLETEDNCT00641095·PHASE2 / PHASE3·University College, London·370 enrolled
rituximabCyclophosphamideFludarabine
T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
TERMINATEDNCT00651716·Vanderbilt-Ingram Cancer Center·150 enrolled
flow cytometrylaboratory biomarker analysisData Collection
Chemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
COMPLETEDNCT00425802·PHASE2·Memorial Sloan Kettering Cancer Center·61 enrolled
anti-thymocyte globulinfilgrastimgraft-versus-tumor induction therapyrituximabcyclophosphamide+5 more
Flavopiridol to Treat Relapsed Mantle Cell Lymphoma or Diffuse Large B-Cell Lymphoma
COMPLETEDNCT00445341·PHASE1 / PHASE2·National Cancer Institute (NCI)·28 enrolled
Flavopiridol
A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies
COMPLETEDNCT00406809·PHASE1 / PHASE2·AbbVie (prior sponsor, Abbott)·81 enrolled
ABT-263
Melphalan, Yttrium Y 90 Ibritumomab Tiuxetan, and Rituximab Followed by Autologous Stem Cell Transplant in Treating Older Patients With Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment
COMPLETEDNCT00392691·PHASE1·Swiss Cancer Institute·20 enrolled
ibritumomab tiuxetanrituximabmelphalanvinorelbine tartrate / G-CSFautologous hematopoietic stem cell harvesting and transplantation